26 related articles for article (PubMed ID: 9057658)
1. DNA mismatch repair in HIV-Associated Lymphoma: Lost in Translation?
Jiang Y; Chen S; Xia M; Xu X; Peng J; Cai S
J Infect; 2024 Mar; 88(3):106112. PubMed ID: 38290665
[No Abstract] [Full Text] [Related]
2. Thymic cancer in lynch syndrome: an unusual association.
Pandey D; Shepro DS
BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32273268
[TBL] [Abstract][Full Text] [Related]
3. Therapy-associated myelodysplastic syndrome with monosomy 7 arising in a Muir-Torre Syndrome patient carrying
Ullman D; Baumgartner E; Wnukowski N; Koenig G; Mikhail FM; Pavlidakey P; Peker D
Mol Clin Oncol; 2018 Feb; 8(2):306-309. PubMed ID: 29435294
[TBL] [Abstract][Full Text] [Related]
4. Selective tumor cell death induced by irradiated riboflavin through recognizing DNA G-T mismatch.
Yuan Y; Zhao Y; Chen L; Wu J; Chen G; Li S; Zou J; Chen R; Wang J; Jiang F; Tang Z
Nucleic Acids Res; 2017 Sep; 45(15):8676-8683. PubMed ID: 28911109
[TBL] [Abstract][Full Text] [Related]
5. Loss of mutL homolog-1 (MLH1) expression promotes acquisition of oncogenic and inhibitor-resistant point mutations in tyrosine kinases.
Springuel L; Losdyck E; Saussoy P; Turcq B; Mahon FX; Knoops L; Renauld JC
Cell Mol Life Sci; 2016 Dec; 73(24):4739-4748. PubMed ID: 27436342
[TBL] [Abstract][Full Text] [Related]
6. Extracolonic manifestations of lynch syndrome.
Bansidhar BJ
Clin Colon Rectal Surg; 2012 Jun; 25(2):103-10. PubMed ID: 23730225
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity.
Horton TM; Jenkins G; Pati D; Zhang L; Dolan ME; Ribes-Zamora A; Bertuch AA; Blaney SM; Delaney SL; Hegde M; Berg SL
Mol Cancer Ther; 2009 Aug; 8(8):2232-42. PubMed ID: 19671751
[TBL] [Abstract][Full Text] [Related]
8. Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.
Horton TM; Thompson PA; Berg SL; Adamson PC; Ingle AM; Dolan ME; Delaney SM; Hedge M; Weiss HL; Wu MF; Blaney SM;
J Clin Oncol; 2007 Nov; 25(31):4922-8. PubMed ID: 17971589
[TBL] [Abstract][Full Text] [Related]
9. Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.
Wu X; Platt JL; Cascalho M
Mol Cell Biol; 2003 May; 23(9):3320-8. PubMed ID: 12697830
[TBL] [Abstract][Full Text] [Related]
10. Frameshift mutations of the hMSH6 gene in human leukemia cell lines.
Hosoya N; Hangaishi A; Ogawa S; Miyagawa K; Mitani K; Yazaki Y; Hirai H
Jpn J Cancer Res; 1998 Jan; 89(1):33-9. PubMed ID: 9510473
[TBL] [Abstract][Full Text] [Related]
11. Possible association between tumor-suppressor gene mutations and hMSH2/hMLH1 inactivation in alveolar soft part sarcoma.
Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Sakamoto A; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2003 Sep; 34(9):841-9. PubMed ID: 14562278
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
Scott S; Kimura T; Ichinohasama R; Bergen S; Magliocco A; Reimer C; Kerviche A; Sheridan D; DeCoteau JF
Leuk Res; 2003 Jan; 27(1):23-34. PubMed ID: 12479849
[TBL] [Abstract][Full Text] [Related]
13. The LL-100 Cell Lines Panel: Tool for Molecular Leukemia-Lymphoma Research.
Drexler HG; Quentmeier H
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823535
[TBL] [Abstract][Full Text] [Related]
14. Mutations and loss of expression of a mismatch repair gene, hMLH1, in leukemia and lymphoma cell lines.
Hangaishi A; Ogawa S; Mitani K; Hosoya N; Chiba S; Yazaki Y; Hirai H
Blood; 1997 Mar; 89(5):1740-7. PubMed ID: 9057658
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the DNA mismatch repair gene hMLH1 in myeloid leukaemias.
Auner HW; Olipitz W; Hoefler G; Bodner C; Konrad D; Crevenna R; Linkesch W; Sill H
Br J Haematol; 1999 Sep; 106(3):706-8. PubMed ID: 10468860
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1.
Wheeler JM; Beck NE; Kim HC; Tomlinson IP; Mortensen NJ; Bodmer WF
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10296-301. PubMed ID: 10468602
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]